269 Views | 250 Downloads
Lindsay J. Collin: lindsay.jane.collin@emory.edu
L.E.M., M.A.T., L.J.C., M.M.G. and S.P. contributed to the study design and conceptualization; L.E.M., L.J.C., K.G. and P.D.S. contributed to the methodology; L.J.C., M.Y., R.J., B.C., L.E.M. and K.W. contributed to the data analysis, curation and interpretation; L.J.C., B.C. and L.E.M. contributed to the original manuscript preparation; L.E.M. and K.W. were responsible for funding ascertainment.
All authors participated in the review and editing of the manuscript for publication.
The authors gratefully acknowledge the contribution of the Greater-Atlanta Breast Cancer Task Force for their contribution to the development of this paper and unwavering efforts to reduce racial disparities in breast cancer mortality in Atlanta.
The authors additionally acknowledge the contributions of Dr. Timothy L. Lash for his support in the development of this project.
K.G. is on the advisory board with Pfizer and Lilly and has received research funding from Pfizer, Calithera, and Merck.
The remaining authors declare no competing interests.
This project was supported, in part, by the Cancer Prevention and Control Research program; and the Winship Research Informatics shared resources, a core supported by the Winship Cancer Institute of Emory University.
The collection of cancer incidence data used in this study was supported by contract HHSN261201800003I; Task Order HHSN26100001 from the NCI; and cooperative agreement 5NU58DP003875-04 from the CDC.
© 2019, The Author(s).